ANDERSON ORTHOPAEDIC RESEARCH INSTITUTE
Programs
Anderson Orthopaedic Research Program
THE FUNDING RECEIVED BY THE ANDERSON ORTHOPAEDIC RESEARCH (AORI) IS USED TO CONDUCT MEDICAL RESEARCH AND QUALITY IMPROVEMENT ACTIVITIES RELATED TO HIP AND KNEE JOINT REPLACEMENT. AORI CONDUCTS BOTH PROSPECTIVE AND RETROSPECTIVE STUDIES WITH THE ULTIMATE GOAL OF SHARING THE INSTITUTE'S FINDINGS WITH THE BROADER MEDICAL COMMUNITY, INCLUDING PATIENTS, THROUGH PUBLICATIONS AND PRESENTATIONS. PROSPECTIVE STUDIES, WHERE VOLUNTEERS CONSENT TO PARTICIPATE, ARE MANAGED BY AORI'S CLINICAL RESEARCH STAFF. THESE STAFF MEMBERS HELP FORMULATE STUDY PROTOCOLS, OBTAIN INSTITUTIONAL REVIEW BOARD (IRB) APPROVAL, CONSENT PARTICIPANTS, SCHEDULE FOLLOW-UP VISITS, ADMINISTER SURVEYS, COMPILE AND ANALYZE OUTCOME DATA, PREPARE IRB REPORTS AS NECESSARY, SUMMARIZE RESULTS FOR STUDY SPONSORS, AND PREPARE ABSTRACTS, PRESENTATIONS, AND MANUSCRIPTS FOR SUBMISSION TO SCIENTIFIC MEETINGS AND PEER-REVIEW JOURNALS. RETROSPECTIVE STUDIES, WHICH USE PRE-EXISTING MEDICAL DATA, ARE CONDUCTED USING INFORMATION OBTAINED AS PART OF ROUTINE PATIENT CARE AND DATA DERIVED FROM AORI'S ELECTRONIC DATABASE THAT ARCHIVES SURGICAL PROCEDURES, CLINICAL VISITS, PATIENT-REPORTED OUTCOME MEASURES, AND ADVERSE EVENTS. BY ANALYZING THIS DATA, AORI STAFF MEMBERS ARE ABLE TO ASSESS THE OUTCOME OF DIFFERENT TYPES OF IMPLANTS AMONG UNIQUE GROUPS OF PATIENTS. THE FUNDING RECEIVED BY AORI SUPPORTS STAFF SALARIES AND BENEFITS, PAYS FOR FEES CHARGED BY AGENCIES THAT OVERSEE AORI'S ACTIVITIES, AND TO PURCHASE STUDY SUPPLIES. COMPUTERS, LABORATORY TESTING EQUIPMENT, AND APPLICATIONS THAT ENABLE THE ACQUISITION AND COMPILATION OF STUDY DATA ARE ALSO PAID FOR WITH THE FUNDS RECEIVED BY AORI. DURING THE PAST YEAR, AORI-AFFILIATED RESEARCHERS PUBLISHED 27 PAPERS IN ORTHOPAEDIC JOURNALS. AORI RESEARCHERS ALSO PRESENTED 37 SCIENTIFIC TALKS, 18 POSTERS AT LOCAL AND NATIONAL ORTHOPAEDIC MEETINGS AND 1 BOOK CHAPTER.GeographiesNot indicatedDatesJun 1, 2024 – May 31, 2025Source990No causes providedNo populations provided–$738.4K
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)